Rights and permissions
About this article
Cite this article
Ixabepilone: further testing warranted in prostate cancer. Inpharma Wkly. 1414, 9 (2003). https://doi.org/10.2165/00128413-200314140-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200314140-00018